Paper Details

  1. Home
  2. Paper Details

Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.

Author: BoavistaRodrigo, ChaconPriscila, CostaDaniel Lucas da Conceição, DinizJuliana Belo, EchevarriaMarco Antonio Nocito, FerrãoYgor Arzeno, FontenelleLeonardo F, LopesAntônio Carlos, MiguelEurípedes Constantino, RosárioMaria Conceição do, ShavittRoseli Gedanke, TorresAlbina Rodrigues, VattimoEdoardo Felippo de Queiroz, da SilvaRenata de Melo Felipe, de BarrosPedro Macul Ferreira, de MathisMaria Alice, de OliveiraMarcos Vinícius Sousa

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study updated the 2013 American Psychiatric Association guidelines for the treatment of obsessive-compulsive disorder (OCD) by reviewing new evidence on pharmacological treatments. The study confirmed that SSRIs remain the first-line treatment, and augmentation with low-dose risperidone or aripiprazole is the most evidence-based approach for SSRI-resistant OCD. The study also identified treatments considered ineffective or potentially harmful.
Paper Details　
Original Abstract of the Article :
OBJECTIVES: To summarize evidence-based pharmacological treatments and provide guidance on clinical interventions for adult patients with obsessive-compulsive disorder (OCD). METHODS: The American Psychiatric Association (APA) guidelines for the treatment of OCD (2013) were updated with a systemati...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154009/

データ提供：米国国立医学図書館（NLM）

Navigating the Complexities of Obsessive-Compulsive Disorder (OCD)

The desert of mental health research is vast and often perplexing. This study sets out to explore the complex world of [psychiatry] and its quest to find effective treatments for obsessive-compulsive disorder (OCD). The researchers embarked on a thorough review of existing evidence, analyzing the efficacy of various pharmacological treatments for OCD. They delved into a treasure trove of research, carefully sifting through data to uncover effective treatments for OCD. Their findings provide valuable guidance for clinicians treating patients with this challenging disorder. The researchers have compiled a comprehensive guide for clinicians, outlining the most effective pharmacological treatments for adult OCD, based on the latest evidence.

SSRIs: A Beacon of Hope for OCD Treatment

The study unveils the effectiveness of selective serotonin reuptake inhibitors (SSRIs) as a first-line pharmacological treatment for OCD. They also found that augmenting SSRIs with antipsychotics can be a beneficial approach for patients who don't respond well to SSRIs alone. This research suggests that SSRIs could be a valuable tool in the management of OCD, offering hope for improved outcomes.

Understanding the nuances of OCD treatment

This study highlights the complexity of OCD treatment and the need for individualized approaches. It emphasizes the importance of considering various pharmacological options, including SSRIs and augmentation strategies, to find the best treatment for each patient. The study underscores the importance of evidence-based practice in mental health care, guiding clinicians toward the most effective treatments.

Dr.Camel's Conclusion

This study provides valuable guidance for clinicians navigating the complexities of OCD treatment. The research underlines the effectiveness of SSRIs as a first-line option and highlights the potential benefits of augmentation strategies. This research serves as a valuable resource for clinicians seeking to provide the best possible care for patients with OCD.

Date :
  1. Date Completed 2023-05-15
  2. Date Revised 2023-05-15
Further Info :

Pubmed ID

36749887

DOI: Digital Object Identifier

PMC10154009

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.